CI
Caz Investments LP
13F filer · CIK 0001159363Reported Aug 24, 2026
Net buyer this quarter
13F portfolio value$549MU.S. long equity reported on 13F
Positions489 new · 1 closed
Net flow last quarter+$224MBuys minus sells
Top 10 positions weight45.5%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 24, 202648 positions | |||||
| $93.4M | 17.02% | 1.97% | +192.6% | Q3 2025 | |
| $30.5M | 5.56% | 6.20% | Not reported | Q4 2022 | |
| $30M | 5.46% | 0.56% | +145.3% | Q4 2020 | |
| $26.4M | 4.80% | Not reported | New | Q2 2026 | |
| $18.6M | 3.39% | 30.96% | +2738.0% | Q2 2021 | |
| $13.8M | 2.51% | Not reported | +100.0% | Q4 2021 | |
| $11.1M | 2.03% | 0.03% | New | Q2 2026 | |
| $11M | 2.00% | 0.02% | +100.0% | Q4 2018 | |
| $8.06M | 1.47% | 0.18% | +100.0% | Q2 2021 | |
| $6.91M | 1.26% | 0.21% | +1689.1% | Q1 2020 | |
| MSMSDLMorgan Stanley Direct Lending Fund | $6.04M | 1.10% | 0.47% | New | Q2 2026 |
| $5.74M | 1.05% | 0.71% | +4482.0% | Q1 2026 | |
| $5.52M | 1.01% | 0.76% | +2523.3% | Q1 2026 | |
| $5.32M | 0.97% | 0.05% | +100.0% | Q1 2026 | |
| $4.56M | 0.83% | 12.01% | New | Q2 2026 | |
| $4.46M | 0.81% | 0.03% | Not reported | Q2 2022 | |
| $4.27M | 0.78% | 0.18% | +106.3% | Q1 2025 | |
| $3.43M | 0.62% | Not reported | -11.1% | Q3 2025 | |
| $2.31M | 0.42% | 0.09% | +60.0% | Q1 2020 | |
| $2.13M | 0.39% | Not reported | New | Q2 2026 | |
| $1.1M | 0.20% | Not reported | New | Q2 2026 | |
| $1.03M | 0.19% | 0.32% | New | Q2 2026 | |
| $371K | 0.07% | 0.00% | +100.0% | Q4 2020 | |
| $343K | 0.06% | 0.02% | +100.0% | Q4 2020 | |
| $209K | 0.04% | 0.00% | +127.6% | Q4 2024 | |
| $183K | 0.03% | Not reported | +100.0% | Q4 2025 | |
| $179K | 0.03% | 0.00% | +100.0% | Q1 2022 | |
| $153K | 0.03% | 0.00% | +100.0% | Q1 2022 | |
| $152K | 0.03% | Not reported | +100.0% | Q1 2022 | |
| $110K | 0.02% | Not reported | +100.0% | Q3 2018 | |
| $101K | 0.02% | 0.01% | +100.0% | Q2 2024 | |
| $94.6K | 0.02% | 0.04% | +50.0% | Q3 2022 | |
| $91.8K | 0.02% | 0.00% | +100.0% | Q2 2018 | |
| $91.4K | 0.02% | 0.01% | Not reported | Q1 2026 | |
| $90.8K | 0.02% | 0.01% | +100.0% | Q4 2022 | |
| $80.9K | 0.01% | 0.02% | Not reported | Q2 2015 | |
| $73.9K | 0.01% | 0.00% | -50.0% | Q1 2026 | |
| $70K | 0.01% | 0.00% | +100.0% | Q1 2022 | |
| $51.8K | 0.01% | Not reported | +20.0% | Q1 2020 | |
| $44.4K | 0.01% | 0.00% | +100.0% | Q2 2018 | |
| $39.6K | 0.01% | 0.01% | +100.0% | Q3 2022 | |
| $33.4K | 0.01% | 0.06% | +100.0% | Q4 2022 | |
| $32K | 0.01% | 0.00% | +100.0% | Q2 2024 | |
| $24.5K | 0.00% | 0.00% | +33.3% | Q4 2022 | |
| $15.5K | 0.00% | 0.04% | +100.0% | Q1 2024 | |
| $13.5K | 0.00% | Not reported | +100.0% | Q4 2022 | |
| CCYDYCytoDyn Inc. | $1.91K | 0.00% | 0.00% | +100.0% | Q2 2020 |
| $1.81K | 0.00% | Not reported | +100.0% | Q3 2025 | |
| Q1 2026Reported May 12, 202640 positions | |||||
| $38.2M | 44.65% | 0.67% | +166.1% | Q3 2025 | |
| $12.4M | 14.53% | 0.23% | Not reported | Q4 2020 | |
| $6.68M | 7.80% | Not reported | Not reported | Q4 2021 | |
| $6.17M | 7.21% | 0.01% | -3.1% | Q4 2018 | |
| $4.08M | 4.77% | 0.09% | Not reported | Q2 2021 | |
| $3.01M | 3.52% | Not reported | Not reported | Q3 2025 | |
| $2.52M | 2.94% | 0.03% | New | Q1 2026 | |
| $2.24M | 2.61% | 0.09% | +104.5% | Q1 2025 | |
| $1.49M | 1.74% | 0.06% | Not reported | Q1 2020 | |
| MCMRCCMonroe Capital Corp | $690K | 0.81% | 0.69% | New | Q1 2026 |
| $685K | 0.80% | 1.09% | Not reported | Q2 2021 | |
| $380K | 0.44% | 0.01% | Not reported | Q1 2020 | |
| $219K | 0.26% | 0.03% | New | Q1 2026 | |
| $184K | 0.21% | 0.01% | Not reported | Q4 2020 | |
| $180K | 0.21% | 0.00% | Not reported | Q4 2020 | |
| $133K | 0.16% | 0.00% | New | Q1 2026 | |
| $124K | 0.14% | 0.02% | New | Q1 2026 | |
| $96K | 0.11% | 0.00% | Not reported | Q4 2024 | |
| $86.5K | 0.10% | 0.01% | Not reported | Q2 2015 | |
| $81.2K | 0.09% | Not reported | Not reported | Q4 2025 | |
| $79K | 0.09% | 0.00% | Not reported | Q1 2022 | |
| $60.2K | 0.07% | Not reported | Not reported | Q1 2022 | |
| $54K | 0.06% | 0.01% | New | Q1 2026 | |
| $48.5K | 0.06% | 0.00% | Not reported | Q2 2018 | |
| $45.4K | 0.05% | Not reported | Not reported | Q3 2018 | |
| $45.2K | 0.05% | 0.00% | Not reported | Q1 2022 | |
| $43.9K | 0.05% | 0.00% | Not reported | Q1 2022 | |
| $40.2K | 0.05% | Not reported | Not reported | Q1 2020 | |
| $37.2K | 0.04% | 0.01% | Not reported | Q2 2024 | |
| $28K | 0.03% | 0.01% | Not reported | Q4 2022 | |
| $23.7K | 0.03% | 0.00% | Not reported | Q2 2018 | |
| $23.2K | 0.03% | 0.03% | Not reported | Q3 2022 | |
| $18.2K | 0.02% | 0.00% | -84.2% | Q3 2022 | |
| $17.1K | 0.02% | 0.03% | Not reported | Q4 2022 | |
| $16.1K | 0.02% | 0.00% | Not reported | Q2 2024 | |
| $12.8K | 0.01% | 0.00% | Not reported | Q4 2022 | |
| $5.4K | 0.01% | Not reported | Not reported | Q4 2022 | |
| $5.3K | 0.01% | 0.02% | Not reported | Q1 2024 | |
| CCYDYCytoDyn Inc. | $1.1K | 0.00% | 0.00% | Not reported | Q2 2020 |
| $786 | 0.00% | Not reported | Not reported | Q3 2025 | |
| Q4 2025Reported Feb 10, 202631 positions | |||||
| $16.9M | 29.18% | 0.25% | +72.2% | Q3 2025 | |
| $14M | 24.19% | 0.23% | Not reported | Q4 2020 | |
| $9.11M | 15.76% | Not reported | -0.3% | Q4 2021 | |
| $5.09M | 8.80% | 0.09% | -0.3% | Q2 2021 | |
| $4.84M | 8.37% | 0.01% | +3.9% | Q4 2018 | |
| $2.25M | 3.90% | Not reported | +50.0% | Q3 2025 | |
| $1.43M | 2.48% | 0.04% | +10000.0% | Q1 2025 | |
| $1.21M | 2.10% | 0.14% | Not reported | Q1 2020 | |
| $134K | 0.23% | 0.02% | +534.4% | Q3 2022 | |
| $101K | 0.17% | 0.00% | -25.0% | Q1 2022 | |
| $96K | 0.17% | 0.00% | +6.5% | Q4 2024 | |
| $78.4K | 0.14% | Not reported | New | Q4 2025 | |
| $74.7K | 0.13% | 0.01% | -74.1% | Q3 2025 | |
| $72.9K | 0.13% | 0.01% | Not reported | Q2 2015 | |
| $65.8K | 0.11% | 0.00% | Not reported | Q1 2022 | |
| $65.1K | 0.11% | Not reported | -50.0% | Q1 2022 | |
| $58.1K | 0.10% | 0.00% | Not reported | Q2 2018 | |
| $55.6K | 0.10% | Not reported | -33.3% | Q3 2018 | |
| $53.3K | 0.09% | 0.00% | Not reported | Q1 2022 | |
| $43.2K | 0.07% | 1.46% | +100.0% | Q3 2022 | |
| $43.1K | 0.07% | Not reported | Not reported | Q1 2020 | |
| $42K | 0.07% | 0.01% | Not reported | Q4 2022 | |
| $34.2K | 0.06% | 0.00% | Not reported | Q2 2018 | |
| $32.8K | 0.06% | 0.01% | -30.0% | Q2 2024 | |
| $23.3K | 0.04% | 0.00% | Not reported | Q2 2024 | |
| $14.7K | 0.03% | 0.03% | Not reported | Q4 2022 | |
| $11.4K | 0.02% | 0.00% | Not reported | Q4 2022 | |
| $7.56K | 0.01% | 0.02% | -54.1% | Q1 2024 | |
| $4.9K | 0.01% | Not reported | Not reported | Q4 2022 | |
| $1.49K | 0.00% | Not reported | Not reported | Q3 2025 | |
| CCYDYCytoDyn Inc. | $1.12K | 0.00% | 0.00% | Not reported | Q2 2020 |
| Q3 2025Reported Nov 12, 202530 positions | |||||
| $14.4M | 26.71% | 0.22% | Not reported | Q4 2020 | |
| $11M | 20.50% | Not reported | Not reported | Q4 2021 | |
| $9.3M | 17.31% | 0.14% | New | Q3 2025 | |
| $6.98M | 12.98% | 0.11% | -26.0% | Q2 2021 | |
| $4.43M | 8.25% | 0.01% | Not reported | Q4 2018 | |
| $1.89M | 3.52% | Not reported | New | Q3 2025 | |
| $1.22M | 2.26% | 0.14% | Not reported | Q1 2020 | |
| $229K | 0.43% | 0.03% | New | Q3 2025 | |
| $145K | 0.27% | Not reported | -23.1% | Q1 2022 | |
| $120K | 0.22% | 0.00% | Not reported | Q1 2022 | |
| $101K | 0.19% | 0.00% | +6.1% | Q4 2024 | |
| $90.6K | 0.17% | Not reported | Not reported | Q3 2018 | |
| $69.8K | 0.13% | 0.00% | Not reported | Q2 2018 | |
| $67.7K | 0.13% | 0.00% | Not reported | Q1 2022 | |
| $63.5K | 0.12% | 0.01% | Not reported | Q2 2015 | |
| $54.7K | 0.10% | 0.00% | Not reported | Q1 2022 | |
| $41.8K | 0.08% | 0.01% | Not reported | Q4 2022 | |
| $41.3K | 0.08% | Not reported | Not reported | Q1 2020 | |
| $37.7K | 0.07% | 0.01% | -33.3% | Q2 2024 | |
| $36K | 0.07% | 0.00% | Not reported | Q2 2018 | |
| $36K | 0.07% | 0.00% | Not reported | Q1 2025 | |
| $29K | 0.05% | 0.04% | -10.5% | Q1 2024 | |
| $25.3K | 0.05% | 0.00% | -50.0% | Q3 2022 | |
| $24.4K | 0.05% | 0.01% | Not reported | Q3 2022 | |
| $20.1K | 0.04% | 0.00% | Not reported | Q2 2024 | |
| $20K | 0.04% | 0.03% | Not reported | Q4 2022 | |
| $13.5K | 0.03% | 0.00% | Not reported | Q4 2022 | |
| $7.25K | 0.01% | Not reported | Not reported | Q4 2022 | |
| $1.85K | 0.00% | Not reported | New | Q3 2025 | |
| CCYDYCytoDyn Inc. | $1.04K | 0.00% | 0.00% | Not reported | Q2 2020 |
Premium opens every quarter this fund has filed